Which of the following would be most likely causing methotrexate therapy failure in ectopic pregnancy treatment.
**Core Concept**
Methotrexate therapy failure in ectopic pregnancy treatment is often due to inadequate suppression of folate metabolism, which is crucial for preventing fetal growth and development. Methotrexate works by inhibiting dihydrofolate reductase (DHFR) enzyme, thereby reducing tetrahydrofolate (THF) synthesis, essential for DNA synthesis in rapidly dividing cells, such as the fetus.
**Why the Correct Answer is Right**
The correct answer is related to the mechanism of methotrexate action. Methotrexate's efficacy in treating ectopic pregnancy depends on its ability to inhibit DHFR, leading to a decrease in THF levels. If this mechanism is impaired, methotrexate therapy may fail. **Option C** is the correct answer because it directly relates to the mechanism of methotrexate action.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not directly relate to the mechanism of methotrexate action in treating ectopic pregnancy. While renal impairment can affect drug clearance, it is not the primary reason for methotrexate therapy failure in this context.
**Option B:** This option is incorrect because it is a common side effect of methotrexate but not a direct cause of therapy failure in ectopic pregnancy treatment.
**Option D:** This option is incorrect because it is not directly related to the mechanism of methotrexate action in treating ectopic pregnancy.
**Clinical Pearl / High-Yield Fact**
It is essential to monitor renal function and liver enzymes when using methotrexate, as impaired renal function or liver disease can affect drug metabolism and increase the risk of toxicity.
**Correct Answer: C. Impaired dihydrofolate reductase (DHFR) enzyme activity.**